Danaher Co. (NYSE:DHR) Shares Sold by First United Bank & Trust

First United Bank & Trust cut its stake in Danaher Co. (NYSE:DHR) by 6.8% in the third quarter, Holdings Channel.com reports. The firm owned 16,603 shares of the conglomerate’s stock after selling 1,215 shares during the quarter. Danaher makes up approximately 2.1% of First United Bank & Trust’s investment portfolio, making the stock its 10th largest position. First United Bank & Trust’s holdings in Danaher were worth $5,055,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. MBM Wealth Consultants LLC grew its position in shares of Danaher by 1.5% during the 2nd quarter. MBM Wealth Consultants LLC now owns 2,418 shares of the conglomerate’s stock worth $649,000 after purchasing an additional 36 shares in the last quarter. First Citizens Financial Corp boosted its position in shares of Danaher by 2.0% during the 2nd quarter. First Citizens Financial Corp now owns 2,154 shares of the conglomerate’s stock worth $578,000 after acquiring an additional 42 shares in the last quarter. Pinnacle Associates Ltd. boosted its position in shares of Danaher by 1.0% during the 2nd quarter. Pinnacle Associates Ltd. now owns 4,209 shares of the conglomerate’s stock worth $1,130,000 after acquiring an additional 42 shares in the last quarter. Carroll Financial Associates Inc. boosted its position in shares of Danaher by 2.1% during the 3rd quarter. Carroll Financial Associates Inc. now owns 2,064 shares of the conglomerate’s stock worth $628,000 after acquiring an additional 43 shares in the last quarter. Finally, Well Done LLC boosted its position in shares of Danaher by 3.1% during the 2nd quarter. Well Done LLC now owns 1,551 shares of the conglomerate’s stock worth $416,000 after acquiring an additional 47 shares in the last quarter. 88.49% of the stock is owned by hedge funds and other institutional investors.

Several analysts recently issued reports on DHR shares. Citigroup increased their price target on shares of Danaher from $345.00 to $370.00 and gave the stock a “buy” rating in a research report on Friday, October 22nd. Bank of America raised their price target on shares of Danaher from $340.00 to $360.00 and gave the company a “buy” rating in a research note on Friday, September 10th. Royal Bank of Canada raised their price target on shares of Danaher from $332.00 to $334.00 and gave the company a “sector perform” rating in a research note on Friday, October 22nd. KeyCorp lifted their target price on shares of Danaher from $315.00 to $345.00 and gave the stock an “overweight” rating in a research note on Friday, October 22nd. Finally, Barclays lifted their price target on shares of Danaher from $335.00 to $355.00 and gave the company an “overweight” rating in a research note on Friday, October 22nd. Two investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of $334.36.

DHR stock opened at $315.48 on Thursday. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.48 and a quick ratio of 1.11. Danaher Co. has a one year low of $211.22 and a one year high of $333.96. The stock has a market cap of $225.43 billion, a PE ratio of 39.98, a P/E/G ratio of 2.35 and a beta of 0.70. The firm has a 50 day simple moving average of $308.25 and a two-hundred day simple moving average of $292.45.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, October 20th. The conglomerate reported $2.39 EPS for the quarter, topping the Zacks’ consensus estimate of $2.15 by $0.24. Danaher had a net margin of 20.97% and a return on equity of 18.32%. The business had revenue of $7.20 billion during the quarter, compared to analysts’ expectations of $7 billion. During the same quarter in the previous year, the company earned $1.72 EPS. The business’s quarterly revenue was up 22.0% compared to the same quarter last year. On average, research analysts expect that Danaher Co. will post 9.8 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, October 29th. Shareholders of record on Thursday, September 30th were paid a $0.21 dividend. The ex-dividend date of this dividend was Wednesday, September 29th. This represents a $0.84 dividend on an annualized basis and a yield of 0.27%. Danaher’s dividend payout ratio is presently 10.65%.

In other Danaher news, Director Linda P. Hefner sold 2,185 shares of the company’s stock in a transaction dated Thursday, November 11th. The shares were sold at an average price of $303.72, for a total transaction of $663,628.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Chairman Mitchell P. Rales sold 343,861 shares of the company’s stock in a transaction dated Tuesday, November 2nd. The shares were sold at an average price of $312.94, for a total transaction of $107,607,861.34. The disclosure for this sale can be found here. In the last three months, insiders sold 694,908 shares of company stock valued at $214,929,432. Corporate insiders own 11.40% of the company’s stock.

About Danaher

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines.

Recommended Story: Risk Tolerance and Your Investment Decisions

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.